Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Onvansertib + Chemotherapy for Colorectal Cancer
Recruiting1 awardPhase 2
Torrance, California
This trial aims to determine the most effective dose of onvansertib and evaluate its safety and effectiveness when combined with certain chemotherapy regimens in patients with a specific type of colorectal cancer that has
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service